What a $199/Month GLP-1 Telehealth Membership Really Covers

$199 a month. $249. $299 all-in. Every GLP-1 telehealth platform leads with a flat monthly number, and every ad you've seen has that number in the biggest font. It's the wrong question.

The right question is what the number buys. Because across the industry, $199 can mean wildly different things — and "all-in" means different things at different companies. Here's the actual breakdown of where your money goes, what's included, and what's quietly billed separately.

The anatomy of a "$199 all-in" charge

Using a typical compounded semaglutide telehealth plan as a benchmark, the rough economic breakdown looks like this:

These numbers are ranges, not precise. Individual platforms run different structures — a budget provider might be $40–60 on drug cost and $15–25 on margin; a premium one might be $50–70 on drug cost and $100+ on clinician time. The point is directional: most of what you pay is not the medication.

What's almost always included

• The initial clinician review (the one that approved your prescription).
• The medication itself at the approved dose.
• Cold-chain shipping of that medication.
• Needles and alcohol pads (usually — check).
• Basic messaging support with the platform.

What's often not included (and where the real cost lives)

This is where the "$199 all-in" framing quietly stops applying. Depending on the platform, any of the following can be billed separately:

1. Dose escalations

Your starting dose of compounded semaglutide is 0.25 mg weekly. At month three you're at 1.0 mg. At month five, 1.7 or 2.4 mg. Some platforms charge the same $199 regardless of dose. Others increase the charge 20–40% at each titration step. Read the terms before you sign up — the "$199 plan" sometimes becomes a $279 plan by month four.

2. Lab work

A good platform recommends or requires baseline labs (metabolic panel, HbA1c, possibly more). Some include this in the plan. Most do not — you pay a third-party lab directly, usually $40–120. A few platforms have partnered with Quest or Labcorp and pass through discounted pricing.

3. Video consult add-ons

If the platform is async by default and you want to actually speak to a clinician, that's often a paid add-on — $30–80 per call. Some platforms offer one free video visit per year and charge for additional.

4. Side effect consults

Severe side effects ideally warrant a conversation, not a chat thread. A few platforms include urgent clinician access; most do not. If you need one, expect $50–100.

5. Prescription paperwork

Need a letter for your employer, insurance appeal, HSA documentation, TSA medication letter for travel, or travel-to-another-country compliance letter? Expect a fee — commonly $25–50 per document.

6. Fast shipping or reshipment

Package lost, delayed, or temperature-compromised? Reshipment is sometimes included, sometimes billed. Read the shipping terms.

7. Cancellation fees

A few platforms charge an "administrative fee" to cancel. A few auto-renew at 30 days and charge you if you try to cancel on day 31. These practices are legal, disclosed in the fine print, and the single largest source of complaints we see.

The three pricing structures to distinguish

Structure A: True all-in

One monthly charge. Medication, titration, labs (sometimes), clinician access, everything. You pay $199/$249/$299 and that's the entire cost. Examples include some of the integrated platforms like Sequence/WeightWatchers Clinic and certain Synergy-style operators.

Structure B: Tiered by dose

You pay more as your dose goes up. This is the most common structure across compounded GLP-1 platforms. Marketed as "$199" but lands at $249–$299 by the maintenance dose.

Structure C: Low base + heavy add-ons

$99 or $129 base. Labs separate. Video visits separate. Documentation separate. Annual memberships separate. By month three you've paid $400+ more than you thought you would. This structure is shrinking under regulatory and reputational pressure but still exists.

What's reasonable to pay, and what isn't

Rough guidance for compounded GLP-1 telehealth as of early 2026:

• Under $160/month: Budget providers. Possible to be legitimate, but economics are tight. Check carefully.
• $180–$280/month all-in for semaglutide or tirzepatide: The mainstream market. Most legitimate operators.
• $280–$400/month: Premium providers with more clinician time, labs included, integrated coaching.
• $400+/month: Rare in compounded; this is where brand-name (Wegovy, Zepbound with insurance copay cards) starts appearing.

What $500/month means

If you see a compounded GLP-1 telehealth plan over $500/month, you're being overcharged. Full stop. The wholesale API cost is low; premium clinician time tops out around $100/visit. Over $500 is the telehealth company printing money, often preying on patients who don't know the price benchmark.

The major exception: brand-name Wegovy or Zepbound without insurance. Those retail for $500–1,350/month in 2026 because Novo and Lilly price them that way, and the telehealth platform has to pay roughly that much wholesale. When the drug itself costs $900, the full charge to you is going to be high — and no amount of platform efficiency changes that.

The actual best deal

For most patients paying out of pocket, the sweet spot is a mainstream compounded platform at the $180–$250 band that includes titration, doesn't charge extra for basic clinician messaging, and doesn't nickel-and-dime for documentation. That's the market median for a reason — it's where price meets reasonable clinician quality and reasonable pharmacy quality.

Paying less than that usually buys you a worse pharmacy, a less attentive clinician panel, or a subscription that quietly increases over time. Paying significantly more usually buys you more access — labs included, more clinician time — not better medication.